Showing results (581-590 of 1,631) with videos related to
Sort By:
Pageof 164
Expert Review of Clinical Pharmacology|May 17, 2025
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-upPaula Alvarez, Arancha Gómez-Cosme, Pablo González Del Pozo, et al.Expert Review of Clinical Pharmacology|April 20, 2025
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptomsLaura Cucinella, Chiara Cassani, Sara Tedeschi, et al.Expert Review of Clinical Pharmacology|November 10, 2025
Impact of gabapentinoids' reclassification policy and COVID-19 on gabapentinoids' utilization pattern and their associated mortality in Scotland and Northern Ireland: a segmental regression analysisAbdullah Alrahmani, Mabast Azeez, Sahar Baker, et al.Expert Review of Clinical Pharmacology|September 24, 2025
Considerations for the treatment of older adults with chronic lymphocytic leukemiaAnna Pula, Tadeusz RobakExpert Review of Clinical Pharmacology|October 16, 2025
Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?Jérémie Tachet, Catia Marzolini, Laurent A Decosterd, et al.Expert Review of Clinical Pharmacology|October 16, 2025
The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disordersHarsharon Kaur Sondh, Christoph Mueller, Delia Bishara, et al.Expert Review of Clinical Pharmacology|July 31, 2014
New problems arising from old drugs: second-generation effects of acetaminophenGisa Tiegs, Khalil Karimi, Kay Brune, et al.Expert Review of Clinical Pharmacology|August 15, 2014
Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?Ingrid T Chen, Roly D GoslingExpert Review of Clinical Pharmacology|December 7, 2013
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®)Florence Salmon, Konstantina Grosios, Harald PetryExpert Review of Clinical Pharmacology|May 10, 2013
Phosphodiesterase inhibitors in clinical urologyStefan Ückert, Markus A Kuczyk, Matthias OelkePageof 164